For the quarter ending 2026-03-31, BIXT had -$46,867 decrease in cash & cash equivalents over the period.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Debt discount amortization, incl. issuance of warrants | - | 0 | - | 0 |
| Interest paid for note conversion | - | 0 | - | 0 |
| Gain/loss of issuance | - | 0 | - | - |
| Acquisition of subsidiary | - | 0 | - | - |
| Acquisition of subsidiary, affiliates | - | 0 | - | - |
| Net loss | -2,068,989 | -522,155 | -282,725 | -1,318,197 |
| Amortization of intellectual property | 2,108 | 2,948 | 4,236 | 4,360 |
| Stock-based compensation expense | 35,838 | 63,645 | 65,487 | 41,267 |
| Stock-based compensation expense, affiliate | 1,278,600 | 53,946 | 125,547 | 27,795 |
| Change in fv of derivative | -73,136 | 15,853 | 264,796 | -497,350 |
| Debt forgivness | - | -133,867 | - | - |
| Shares due for debt conversion affiliates | - | - | - | 0 |
| Increase in pre-payments | -3,551 | 3,551 | - | - |
| Shares due for debt conversion | - | - | - | 8,510 |
| Accounts payable and accrued expenses | 215,868 | -199,257 | 72,985 | 622,193 |
| Accounts payable and accrued expenses affiliates | - | 517,173 | 246,302 | -131,288 |
| Accounts payable affiliates | 221,278 | - | - | - |
| Net cash used in operating activities | -238,610 | -236,971 | -41,474 | -248,010 |
| Investment in intangibles | 9,227 | 6,240 | 1,674 | 15,177 |
| Net cash used in investing activities | -9,227 | -6,240 | -1,674 | -15,177 |
| Proceeds from stock sales | - | - | - | 0 |
| Stock subscription for cash | - | - | 13,353 | - |
| Short-term loans | - | 10,000 | 2,000 | 0 |
| Proceeds from note sales | - | 0 | - | 0 |
| Stock transactions | 145,701 | 438,986 | - | - |
| Short-term loans, affiliates | -40,070 | 10,763 | 39,150 | 261,177 |
| Issuance of warrants | 95,339 | 292,230 | - | - |
| Net cash provided by financing activities | 200,970 | 738,626 | 54,503 | 261,177 |
| Net increase (decrease) in cash | - | 495,415 | - | - |
| Net decrease in cash | -46,867 | 495,415 | 11,355 | -2,010 |
| Cash, beginning of period | 509,914 | 14,499 | 5,154 | - |
| Cash, end of period | 463,047 | 509,914 | 14,499 | - |
BIOXYTRAN, INC (BIXT)
BIOXYTRAN, INC (BIXT)